Compare NERV & HCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NERV | HCKT |
|---|---|---|
| Founded | 2007 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 301.6M | 324.6M |
| IPO Year | 2014 | 1998 |
| Metric | NERV | HCKT |
|---|---|---|
| Price | $5.31 | $11.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $10.50 | ★ $17.00 |
| AVG Volume (30 Days) | 129.8K | ★ 419.5K |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.67% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.17 |
| Revenue | $41,175,600.00 | ★ $285,862,000.00 |
| Revenue This Year | N/A | $2.55 |
| Revenue Next Year | N/A | $5.07 |
| P/E Ratio | ★ N/A | $62.41 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.35 | $9.16 |
| 52 Week High | $12.46 | $25.97 |
| Indicator | NERV | HCKT |
|---|---|---|
| Relative Strength Index (RSI) | 42.85 | 47.85 |
| Support Level | $5.02 | $9.16 |
| Resistance Level | $6.69 | $14.49 |
| Average True Range (ATR) | 0.42 | 0.75 |
| MACD | -0.07 | 0.05 |
| Stochastic Oscillator | 46.96 | 39.62 |
Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.
The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.